American International Group, Inc. Arcutis Biotherapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.25 - $11.77 $1,088 - $3,942	-335 Reduced 0.85%	38,976 $386,000
Q4 2023 Feb 13, 2024	BUY	$1.84 - $4.82 $25,117 - $65,797	13,651 Added 53.2%	39,311 $126,000
Q3 2023 Nov 13, 2023	BUY	$5.31 - $10.98 $4,842 - $10,013	912 Added 3.69%	25,660 $136,000
Q2 2023 Aug 04, 2023	BUY	$7.51 - $15.0 $35,417 - $70,740	4,716 Added 23.54%	24,748 $235,000
Q1 2023 May 12, 2023	BUY	$10.23 - $17.14 $4,081 - $6,838	399 Added 2.03%	20,032 $220,000
Q4 2022 Feb 10, 2023	BUY	$13.96 - $20.4 $3,252 - $4,753	233 Added 1.2%	19,633 $290,000
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $53,657 - $81,011	3,006 Added 18.34%	19,400 $371,000
Q2 2022 Aug 12, 2022	BUY	$16.33 - $22.2 $43,454 - $59,074	2,661 Added 19.38%	16,394 $349,000
Q1 2022 May 13, 2022	SELL	$14.38 - $22.79 $13,905 - $22,037	-967 Reduced 6.58%	13,733 $264,000
Q4 2021 Feb 11, 2022	SELL	$14.98 - $25.5 $6,576 - $11,194	-439 Reduced 2.9%	14,700 $305,000
Q3 2021 Nov 12, 2021	SELL	$19.28 - $27.1 $6,940 - $9,756	-360 Reduced 2.32%	15,139 $362,000
Q2 2021 Aug 13, 2021	BUY	$24.42 - $34.75 $49,523 - $70,473	2,028 Added 15.05%	15,499 $423,000
Q1 2021 May 07, 2021	BUY	$24.47 - $36.98 $35,065 - $52,992	1,433 Added 11.9%	13,471 $390,000
Q4 2020 Feb 12, 2021	BUY	$17.82 - $31.73 $21,882 - $38,964	1,228 Added 11.36%	12,038 $339,000
Q3 2020 Nov 04, 2020	BUY	$23.44 - $32.28 $117,504 - $161,819	5,013 Added 86.48%	10,810 $317,000
Q2 2020 Aug 12, 2020	SELL	$24.48 - $36.56 $8,861 - $13,234	-362 Reduced 5.88%	5,797 $175,000
Q1 2020 May 04, 2020	BUY	$18.5 - $36.9 $113,941 - $227,267	6,159 New	6,159 $184,000

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

Jennison Associates LLC

11.7M
Shares

$108 Million
0.07% of portfolio
Rubric Capital Management LP New York, NY

11M
Shares

$102 Million
2.84% of portfolio
Suvretta Capital Management, LLC New York, NY

10.7M
Shares

$99.3 Million
3.92% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

8.79M
Shares

$81.4 Million
4.4% of portfolio
Black Rock Inc. New York, NY

8.62M
Shares

$79.8 Million
0.0% of portfolio

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account